Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Open in API
Filings indexed 267 across all filing types
Latest filing 2025-12-22 Annual Report
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company Anterogen, which is the Korean equivalent of an Annual Report (10-K). It contains comprehensive financial information, management discussion, governance details, and audit information for the fiscal year 2024. The document is clearly a full annual filing rather than an announcement or a summary. FY 2024
2025-12-22 Korean
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Anterogen' for the period ending March 31, 2025. It contains detailed financial data, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Although it includes a section on '정정사항' (corrections), the document itself is the full quarterly report filing, not merely an announcement of the report. Q1 2025
2025-12-22 Korean
[기재정정]반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Half-Year Report) for the company 'Anterogen' (안트로젠), covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial data, management discussions, and operational information, which aligns with the definition of an Interim/Quarterly Report (IR). Although it is labeled as a 'correction' (정정), the core content is the comprehensive interim financial report itself. H1 2025
2025-12-22 Korean
[기재정정]분기보고서 (2025.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Anterogen' covering the period from January 1, 2025, to September 30, 2025. It contains detailed financial data, business operations, management discussions, and shareholding information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-12-22 Korean
[기재정정]분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Anterogen' (주식회사 안트로젠). It contains detailed financial information, business descriptions, and management disclosures for the period ending September 30, 2021. Although the document includes 'correction' (정정) notices dated 2025, the core content is a comprehensive quarterly financial report, which falls under the 'Interim / Quarterly Report' category. 9M 2021
2025-12-22 Korean
[기재정정]반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Anterogen' (안트로젠). It contains detailed financial information, business descriptions, management discussions, and shareholding status for the first half of the 2025 fiscal year. Although it includes a section on 'corrections' (정정신고), the document itself is a comprehensive interim financial report, which falls under the 'Interim / Quarterly Report' category. H1 2025
2025-12-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.